News

Curaleaf has launched cannabis’s first hostile takeover bid since 2019 and Aurora has rejected it. The real fight is over the EU-GMP supply that feeds Europe.

The FSA recommends authorising three CBD applications capped at 10 mg a day: some 3,000 products leave limbo while the EU stays stuck.

Portugal exported 66.3 tonnes of medical cannabis in the first half of 2026, 83% of all 2025. Spain is now its second destination with 11.4 tonnes.

Spain will review its medical cannabis decree before the end of 2026. What could change in dispensing, and what it means for producers and labs.

France sent the medical cannabis reimbursement decree to the Conseil d’État on 2 July. No prescriptions under the permanent framework before 2027.

Brussels proposes recognising the whole hemp plant, flower included, as an agricultural product with CAP access. What changes for the sector from 2027.

BfArM has revised Q1 2026 upward to 67.5 tonnes imported. What Germany’s new record means for European producers, distributors and investors.

Curaleaf bids US$4.00 a share for Aurora to secure 50+ tonnes of EU-GMP capacity, while Canopy and SNDL certify plants. Europe now sets the price.

EFSA sets a provisional safe level of about 2 mg of CBD per day. What changes for hemp manufacturers, distributors and brands across the EU.